NCT07570615Not yet recruiting
Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension
Development and Validation of a Chinese Patient-Reported Outcome Measure for Quality of Life in Pulmonary Arterial Hypertension Patients
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This study aims to develop and validate a culturally appropriate, reliable, and clinically applicable patient-reported outcome (PRO) instrument to assess quality of life in patients with pulmonary arterial hypertension (PAH) in China. The study includes two phases: (1) scale development using literature review, Delphi expert consultation, and patient interviews; and (2) multicenter prospective observational validation to evaluate reliability, validity, and responsiveness. The final scale is expected to support clinical assessment, treatment monitoring, and health policy decision-making.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 30 Apr 2026
- Start date
- 1 Dec 2026
- Primary completion date
- 30 Apr 2029
- Lead sponsor
- Chinese Pulmonary Vascular Disease Research Group
- NCT number
- NCT07570615
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Dec 2026 to the primary completion date, 30 Apr 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe physical condition preventing participation
- History of psychiatric disorders or current use of psychiatric medication
- Any condition preventing completion of questionnaires
Other
- Pregnancy or lactation
Who the study is looking for
- Age ≥18 years
- Diagnosed with pulmonary arterial hypertension
- Able to read and complete questionnaires
- Provided informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.